Comments
Loading...
Cabaletta Bio (CABA) Forecast
NewsEarningsCabaletta Bio (CABA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCabaletta Bio (NASDAQ:CABA) Stock Quotes, Forecast and News Summary
Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cabaletta Bio (CABA) stock?
You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.
Who are Cabaletta Bio (CABA) competitors?
Other companies in Cabaletta Bio’s space includes: Atossa Therapeutics (NASDAQ:ATOS), PepGen (NASDAQ:PEPG), Abpro Hldgs (NASDAQ:ABP), Tonix Pharmaceuticals (NASDAQ:TNXP) and Lineage Cell Therapeutics (AMEX:LCTX).
What is the forecast, or price target, for Cabaletta Bio (CABA) stock?
Cabaletta Bio has a consensus price target of $24.00.
What is the current price for Cabaletta Bio (CABA)?
The stock price for Cabaletta Bio (NASDAQ: CABA) is $2.32 last updated December 23, 2024 at 9:41 AM EST.
Does Cabaletta Bio (CABA) pay a dividend?
There are no upcoming dividends for Cabaletta Bio.
When is Cabaletta Bio (NASDAQ:CABA) reporting earnings?
Cabaletta Bio’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Cabaletta Bio (CABA) going to split?
There is no upcoming split for Cabaletta Bio.
What sector and industry does Cabaletta Bio (CABA) operate in?
Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.